INTRODUCTION
A radiotherapy treatment starts with the acquisition of a computerized tomography (CT) scan, which is used to plan an individualized treatment for the patient. The treatment is then delivered over several weeks, based on the premise that the anatomy is unchanged since the planning stage. Possible changes are considered by including treatment margins when delineating volumes of interest. Patient positioning verification is performed using image-guidance. Cone-beam CT (CBCT) is a popular imaging method that provides valuable 3D information of the patient in treatment position. However, the imaging quality is inferior compared to CT, 1 resulting in incorrect Hounsfield units (HU) for dose calculations. 2 It is well known that patient's anatomy can vary within a fraction, with swallowing and respiratory motion, 3 and from fraction to fraction, with changes in bladder/bowel filling and tumor shrinkage. 4 The concept of adaptive radiotherapy (ART) suggests a change of paradigm in radiotherapy: 5 the stationary anatomy is replaced by a variable anatomy, by utilizing daily imaging in the radiotherapy process. 6 ART is a very broad subject and full clinical implementation requires further developments in computational power, image guidance, dose verification, and plan adaptation. 6, 7 It is widely accepted that deformable image registration (DIR) algorithms will play a vital role in ART: [8] [9] [10] the planning CT (pCT) can be deformed to match the daily anatomy (CBCT) for calculating the "dose of the day," the deformation field can be used for automatic recontouring and the daily dose distributions can be warped back to the pCT for dose summation. 11 This study is focused on head and neck (HN) patients. Several studies show that HN patients' anatomy changes during the course of the treatment, and that this results in dosimetric changes from the original plan. 4, 12, 13 It is clear that some patients require at least one replan, 14 but it is not clear which benefits the most from ART and when is the right time for intervention. Currently, in University College London Hospital (UCLH) the decision to replan is based on clinical experience and offline review of CBCTs acquired. A more desirable approach would be to estimate the dose actually received by the patient during treatment ("dose of the day"), and use this dosimetric information to feed the decision-making process.
To calculate the "dose of the day" and assess if the current plan is still acceptable, an image of the patient in treatment position with structures of interest delineated is necessary, and DIR can provide a solution to answer both those needs. We optimized a DIR algorithm implemented at our institution for CT-to-CBCT registrations in HN patients, and investigated its suitability to correctly estimate the "dose of the day" for an intensity modulated radiation therapy (IMRT) treatment. Two other common approaches suggested in the literature to calculate the "dose of the day" are based on image guidance with CT imaging, 15 and direct dose calculations on the CBCT, using pixel correction techniques 16, 17 or relative electron density calibration. 18, 19 The first increases the dose given to the patient in the image guidance protocols and requires an in-room CT scanner, which is not available in our practice. The second is more limited by the inherent properties of CBCT imaging, such as proneness to motion artifacts, increased noise, reduced contrast, and limited field-of-view (FoV). It also requires delineation of structures of interest, which can be challenging in a CBCT scan.
DIR validation is challenging due to the lack of gold standards in clinical and nonclinical settings. 20 While there is a wide variety of studies assessing the quality of CT-CT deformable registration with patient data, 8, 21 for CT-CBCT the studies are scarcer and usually focused on the deformation properties rather than dosimetry. [22] [23] [24] [25] In this work we use image inspection, feature-based evaluation, and comparison of dose distributions to assess the suitability of our DIR algorithm implementation for the clinical application of dose calculations in HN patients.
METHODS AND MATERIALS

2.A. Patient data acquisition
Retrospective data from five head and neck patients treated in our clinic and referred for possible replan was used in this study (Table I ). All patients underwent IMRT with a planned dose of 65 Gy delivered in 30 daily fractions. Patient positioning was assured by appropriate head-rest and a personalized HN and shoulder mask.
The imaging protocol consisted of a planning CT (GE Widebore 16 slice system) with contrast injection, and weekly CBCTs (On-board imaging v1.4, Varian Medical Systems, Palo Alto, CA) acquired in treatment position. The CBCTs were acquired in half-fan mode, full rotation, 110 kVp, 20 mA, 20 ms, with a maximum FoV of 45 cm in diameter, and 16 cm in length. Imaging resolution was 0.977 × 0.977 × 2.5 mm and 0.879 × 0.879 × 2 mm for the CT and CBCT scans, respectively.
The treatment isocenter is usually set to bony anatomy on the identifiable vertebrae and does not represent any normalization point or high dose region. The CBCT is aligned to the pCT following a standardized online image guidance protocol for isocenter alignment based on manual rigid registration to the cervical spinal vertebrae.
Replanning referral occurred when the CBCT offline review study found the spinal canal or brainstem outside their respective planning organ at risk volume, the external contour decreased more than 5 mm and/or if the immobilization mask was no longer effective. By rigidly aligning the pCT with the CBCT and defining the new body external contour on the pCT based on the CBCT external, target coverage and possible overdosage to organs-at-risk (OARs) were verified, and the decision to replan taken. Four of these patients were replanned midway. A replan CT (rCT) was acquired in the same scanner as the pCT (with contrast) and a new plan built from scratch-a new immobilization mask was necessary but the previous positioning was reproduced as close as possible. Typically the last two weeks of treatment were completed with the new plan.
2.B. NiftyReg
NiftyReg is an open-source registration package implemented by our institution's Centre of Medical Image Computing (http://cmic.cs.ucl.ac.uk/home/software/). While the affine registration implemented in NiftyReg uses a Block Matching-based approach, 26 the deformable registration is a GPU implementation of the popular B-spline Free Form Deformation algorithm using Normalized Mutual Information (NMI) as similarity measure. 27, 28 The registrations were defined by a set of parameters previously optimized to suit the datasets being registered. 29, 30 NiftyReg implements a multiresolution approach, and our registrations were carried out using three resolution levels. The B-spline control point grid is placed on the CBCT by aligning the second control point with the centre of the first voxel, as shown in Fig. 1(a) . The control point spacing equals five voxels.
Two regularization terms were used: bending energy, which encourages a smoothly varying deformation field, 27 and logarithm of the determinant of the jacobian, which penalizes large volume changes. 31 A folding correction scheme is applied every iteration and to the final deformation field. When folding occurs the correction scheme updates the control point coefficients in the vicinity of folded voxels to try and produce a folding-free transformation. 32 The folding correction scheme ensures the invertibility of the deformation field.
NMI metric with 32 bins was preferred as similarity measure over other popular measures, such as the sum of squared differences (SSD) and global cross-correlation (CC), since it handles not only the nonlinear relationship between CT and CBCT intensities but also the local variations of intensity characteristic of CBCT imaging. The registrations were optimized using a conjugate gradient optimization. In our pipeline, the patient images and structures were exported from the treatment planning system (TPS) in DICOM format to a standalone registration workstation. Our registration workstation had an Intel Xeon CPU E25606 (2.13GHz, 12GB RAM) with a NVIDIA Tesla C2070 GPU card (14 multiprocessors, 6 GB dedicated memory). A rigid registration was first applied in order to estimate the global alignment between the pCT and the CBCT. The obtained transformation was then used to initialize the deformable registration. The deformable registrations using images at full resolution ran in approximately 1 min. The output deformation field was used to propagate the contours from the planning CT to the deformed CT, and the results saved in DICOM format. Both the deformed CT and warped structures were then imported back in the TPS for dose calculations.
A well-known issue with CBCT imaging is that the limited FoV often makes the images unusable for treatment planning due to missing patient information. 19 Methods proposed to handle this issue include acquiring two consecutive CBCTs, 33 or directly using pCT slices to extend the CBCT. 11 We estimated the deformation outside the CBCT FoV by continuity, using the initial rigid alignment and the regularization of the deformable registration. The CBCT volume was extended in the superior/inferior direction, to cover the whole CT FoV. Figure 1 (b) shows the effect this has on the B-spline control point placement. The deformation outside the FoV was initialized using the rigid alignment. During the registration the transformation is optimized over the whole of the extended volume-as there is no image data to drive the registration outside the field it is purely driven by the constraint terms in these regions. This has the effect of causing a smooth transition between the image driven deformation inside the field of view and the rigid alignment outside the FoV. A good rigid alignment between the pCT and CBCT is then required, and it provides a good approximation mostly in the superior region, as the patient's head moves in a rigid fashion. The superior region is usually the most important due to presence of OARs such as brainstem and parotids. The brainstem only moves rigidly, but the parotids can shrink and migrate, 12 and if not imaged the registration will likely represent the wrong deformation.
2.C. Evaluation of the DIR suitability for "dose of the day" calculations
Two independent tests were performed to assess the appropriateness of our registrations methodology for "dose of the day" calculations in a deformed CT. A geometric evaluation was performed to assess the ability of our DIR method to map identical structures between the CT and CBCT datasets. Features delineated in the pCT were deformed using the output deformation field and compared with the same features manually drawn on the CBCT. We compared the results obtained with those of using a rigid-only registration of the vertebrae. A dosimetric evaluation was performed to evaluate the impact of the registrations errors in the application proposed, to identify the limitations of our out-of-field approximation and assess how our method compares with other approaches. Dose distributions for the same IMRT plan were calculated on the deformed pCT and rCT, and compared. In this second test our method results were compared not only with those from a rigid-only registration of the vertebrae, which approximates our institution's current alignment protocol, but also with dose calculations directly on an calibrated and extended CBCT.
16, 17
2.C.1. Geometric evaluation
The purpose of this test was to assess the DIR ability to align the same anatomical features in CT and CBCT images. For each patient a set of easily identifiable features was drawn by the same clinical expert on both the pCT and the CBCT (Fig. 2) . The CBCT used for each patient was the last acquired before replan referral. Due to the noise and low contrast inherent to CBCT imaging, it is difficult to delineate points or delineate structures with confidence and consistency. The features were chosen to be structures that could be unequivocally identified in both scans and that gave an indication of how well the registration accounts for patient positioning errors and weight loss. Vertebrae C1, C4, and C7 were used because they are only subject to rigid motion and cover the length of the cervical spinal canal. External body contour and right and left sternocleidomastoid muscles were used as soft tissue structures. The two muscles are adjacent to the region that contains the neck lymph nodes. Deformation between scans may affect their shape and position, and therefore nodal dose. 34 Typical HN OARs, such as parotids and brainstem, were not considered in this evaluation because they cannot be unequivocally seen in a CBCT scan.
Considering that A and B are the set of voxels that define the volumes of the manual and deformed features whileÃ and B define the corresponding surfaces, three metrics were used to describe the similarity between the features:
r Distribution of Euclidean distances between surfaces' points, also known as the distance transform (DT).
DT was computed bi-directionally and properties of the distribution, such as mean value, were calculated.
r Centroid position error (CoM)
The metrics presented provide complementary information about the overlap between volumes (DSC), closeness between the surfaces (DT), and spatial positioning of the features (CoM).
2.C.2. Dose comparison
In this second test our aim was to show that we can deform the pCT into an image which is functionally equivalent to a rCT as far as dose calculation is concerned. To test this hypothesis, four different dose distributions were computed for each patient:
(i) recalculated dose in the rCT (D rCT ), considered as gold-standard; (ii) recalculated dose in the deformed pCT, (D DIR ), the method we propose; (iii) recalculated dose in a rigidly aligned pCT (D RIG ), our current clinical approach; (iv) recalculated dose in a calibrated CBCT with superior/inferior extension (D CBCT ).
In an ideal situation the rCT and CBCT would have been acquired at the same time, or at least in the same day, so that the two modalities contained the same (or comparable) geometric information. However, using retrospective data such effort is not possible since there is no clinical reason to acquire a CT and a CBCT on the same day. The CBCT used for each patient was the one acquired on the first fraction of the second plan. Since the rCT and following CBCT are not acquired simultaneously, but 5-7 days apart, noticeable changes to the patients' positioning and anatomy can occur between the scans. To minimize the errors in dose estimation due to discrepancies between the rCT and the CBCT, we actually registered the pCT to a simulated CBCT, obtained by deforming the real CBCT to match the rCT. This simulated CBCT is closer to the ideal dataset discussed above. We could have deformed the rCT to match the CBCT instead but we opted against it for three reasons: (i) since we are trying to reproduce the dose calculated on a rCT we did not want to modify the rCT in any way, (ii) the plan isocenter is intrinsically defined in the rCT (further explanation on this point below), and (iii) since CBCT inherently has lower imaging quality possible errors in the deformed CBCT will be less noticeable than similar errors in deforming the rCT. To calculate D CBCT the simulated CBCT values were replaced, pixel by pixel, with CT values and the image was extended in the superior and inferior direction using the corresponding rigidly aligned pCT slices. The relationship between CT and CBCT values was obtained using the Catphan-504 (Phantom Laboratory, NY) calibration phantom. Images of the phantom were acquired and the average HU for each of its constituting materials was calculated for each of the imaging modalities. The conversion curve between CT and CBCT numbers was approximated by a quadratic polynomial. Figure 3 shows the data used and registrations performed for each patient.
Doses were calculated for an IMRT plan using Varian Eclipse External Beam Planning System analytical anisotropic algorithm with the highest available resolution (1 mm). For each patient the same IMRT plan, including beam arrangement, monitor units and fluence maps, were employed. The choice of IMRT plan should be clinically relevant, so a dose distribution the patient was treated with was chosen. The plan chosen to perform the dose calculations was the replan, which was built and optimized in the rCT. This minimizes the issues with the isocenter definition both in the gold-standard, our method and extended CBCT. The uncertainties with isocenter positioning are only an issue when calculating D RIG . The isocenter uncertainty positioning in this case was dealt with by using our clinical protocol for isocenter alignment (described in Sec. 2.A).
The dose distributions were compared considering dosedifferences (DD), gamma analysis, and similarity of the 95% isodose region (representing target coverage).
The gamma analysis method compares a reference (D ref ) and calculated (D cal ) dose distributions using acceptance criteria. 35 
2.C.3. Propagation of structures and "dose of the day"
The dose analysis was extended to examine the impact within different OARs. In clinical settings, dose volume histograms (DVHs) are routinely used to assess if the plan is appropriate for the patient, by displaying in a concise and comprehensive way the information of dose delivered both to targets and OARs. DVHs were computed using both manually drawn and warped structures of interested. The structures were delineated by the radiographers as part of clinical practice. Complementary to DVH analysis, overlap between OARs manually drawn in the rCT and warped from the pCT was also assessed. Figure 4 shows a representative example of the matching of manual and warped features. The visual matching of the features is satisfactorily after registration, particularly for complexly shaped features such as the vertebrae.
RESULTS
3.A. Geometric evaluation
In Table II we present the mean DSC, DT, and CoM obtained for different types of features. Figure 5 shows the complete information of the distribution of DT values, for different feature and registration types. DIR aligns the features well and considerably better than rigid registration, and the results obtained are more consistent between different structures types. The results obtained are also poorer in soft tissue region than in bone anatomy. Inherent lower soft tissue contrast in the CBCT degrades both the registration accuracy and the quality of manual segmentations. The tail of the DT distribution, and consequently maximum DT values, are thought to be more related with local poor manual segmentation than to registration errors.
3.B. Dose comparison
Overall D DIR matches D rCT well (Fig. 6) . The dose similarity results were analyzed based on different regions of the For a particular patient the 95%-isodose curve similarity was considerably poorer when compared with the results obtained for the remaining patients. We observed that the CBCT was acquired more superiorly than usual, and so the inferior volume of the high dose region was not fully imaged. As a result, for this particular patient our estimation outside the FoV was not adequate in the inferior direction (where the transformations are not majorly rigid). The DD inside the OARs are most relevant clinically (Fig. 7) . D DIR dose-differences are clinically insignificant inside OARs, and the results found are superior to those from other dose estimation approaches. The poor image quality of the CBCT in the inferior direction (i.e., neck and shoulders) is responsible for the inferiority of D CBCT in comparison with D DIR . This affects both the dose estimation in the high dose region (Table III and Fig. 6 ) and in the spinal canal (Fig. 7) . The inconsistency in HU is less problematic in the remaining OARs. respectively. From Fig. 8 it can be seen that differences in DVHs were mainly due to differences in the OARs definition (manual vs warped) and not due to differences in dose estimation (D rCT vs D DIR ). The same trend was found for the errors in estimating the maximum and mean doses to an OAR ( D max and D mean ). Using D DIR combined with manually drawn structures on the rCT the mean value obtained for D mean was 0.1% ± 0.1% of the prescribed dose (pD) (range: 0.0%-0.3%pD), while for D max was 0.3% ± 0.2%pD (range: 0.0%-0.6%pD). However, using the warped structures these errors increased to 2.4% ± 2.1%pD (range: 0.3%-7.8%pD) and 1.5% ± 1.6%pD (range: 0.1%-6.2%pD), respectively.
3.C. Propagation of structures and "dose of the day"
DISCUSSION
Regarding the geometric evaluation, all metrics showed an improvement when comparing deformable to rigid registration, up to a relative improvement of 80%. The values found for DSC are comparable to the ones obtained by Castadot et al. using CT-CT DIR. 36 DT metrics and CoM values were comparable to image resolution. Combining the DSC, DT, and CoM we can evaluate the ability of the DIR method to map identical structures between the CT and CBCT datasets. However, each of these quantities can be misleading on its own. For example, DSC is inherently bigger for larger structures, such as the external contours, and in this case DT is a better measure of similarity between features.
One of the main limitations of our geometric evaluation is not including localization of anatomical landmarks. Anatomical landmarks were not used in this study due to the difficulty detected by our clinical expert in consistently identifying points in a CBCT image. The uncertainty in landmark locations could produce misleading accuracy results, so we opted to only use structures in the geometric evaluation. Furthermore, we consider that for our current goal of calculating the "dose of the day" accurate point-to-point mapping is not required.
The method presented allows for accurate dose calculations, comparable to doses recalculated on a replan CT and superior to both our current clinical approach and dose calculations on the CBCT (with extended FoV). CBCT images include larger amounts of scattering than CT, resulting in larger variation in HU values that limit the HU calibration and reliability. 1 The CBCT calibrations are done using a small phantom which provides consistent results in such a small FoV. However, for larger volumes the calibration is no longer consistent which has a considerable impact in dose calculations. Figure 6 shows the effect in dose estimation of such inconsistency in HU in the neck and shoulders region. Imaging larger volumes result in increased scatter and reduced transmission. The increase in scatter introduces nonuniformities and additional quantum noise to the reconstructed image. 37 This indicates the need for more specific and appropriate calibration phantoms for CBCT, which should cover the size of the treatment region. The choice of phantom is crucial as others showed different phantoms result in very different relative electron density calibration curves, and particularly the Catphan may not be the most appropriate due to issues with its bone-equivalent material. 18 While we think our results are indicative of how reliable CBCT currently is for direct dose calculations, it was not in the scope of this paper to optimize treatment planning on CBCT images. Our imaging protocol was not optimized for that purpose, and so the calculations were clearly suboptimal. In our opinion calculating dose distributions directly on CBCT images is still an active area of research and the fact that specialized calibrations and optimizations are required is a current disadvantage of such methods. The deteriorated image quality of CBCT leads to serious concerns about its reliability for direct dose calculations. CT is still far superior to CBCT for treatment planning, and DIR is a good interim solution for ART until CBCT data are directly usable.
Our results show promise to obtain dosimetric information even outside the CBCT FoV. The interpolation of the information outside the FoV allows performing dose calculations even when the CBCT FoV is smaller than the treatment FoV. Although we do propose a method for estimating the transformation, and hence the anatomy, outside of the CBCT FoV, we do not claim this will always give trustworthy results. If there is significant deformation outside the FoV then our method will not be able to recover this. Such deformations occurred for one of the patients included in our study where the CBCT field of view did not extend far enough in the inferior direction. Further research will be required to study the validity of our approximation outside the on-board imaging. For future clinical applications, the imaged region must be selected properly to minimize possible out of field errors on critical regions of the individual patient. For example, if the major concern is the dose given, to the brainstem, then the brainstem should be imaged. If target coverage is more important, the high dose region should be properly captured. Informing the imaging procedures will be even more important for bigger patients and/or tumors. Figure 8 shows how structure delineation has an important impact in plan evaluation. Structure contours deviations explain the differences in DVHs and mean/maximum doses to OARs. The overlap found between OARs is similar to values reported by Tsuji et al. for CT-CT DIR. 8 Visually we find that most discrepancies in spinal canal and brainstem are actually due to differences in defining the extent of these organs in the superior direction in the different scans. Generating appropriate structure delineations for ART is an important and on-going area of research, 8, 21, 24 which is beyond the scope of this paper. In future applications of the tool presented and validated here, deformed structures will be used as a starting point to speed up the evaluation process, but will likely require manual verification and editing to be used clinically. Extra care must be taken if modifying targets during ART. Even though authors suggest the use of DIR to monitor tumor shrinkage, 38 in our case warping target volumes may not be appropriate as they are usually not visible in CBCT imaging. Also, even if the gross tumor volume (GTV) shrinkage is visible, there is no evidence that microscopic proliferation has shrunk in the same proportion. Guidelines for target propagation are still being developed by our group and others. Including routine functional imaging, such as magnetic resonance imaging (MRI), in the ART workflow may provide not only a solution for target propagation but also early evidence of the patient response to the treatment. 39, 40 We have validated the use of DIR for calculating the "dose of the day," but this does not necessarily guarantee correct point-to-point matching. Point-to-point matching is important when handling dose remapping and summation, but is very difficult to validate because the true correspondence is unknown. 21 Dose remapping and summation is very sensitive to the actual displacement map since small errors in deformation can result in significant changes in dose at points in high dose gradient regions. 41 Additionally, warping the "dose of the day" back to the original pCT for summation requires the inverse of the pCT-CBCT transformation. Therefore, symmetric and diffeomorphic registrations are desired to ensure invertibility and remove bias from the direction of the registration. Such approaches are currently being investigated, 31 and preliminary results indicate that our DIR framework can be successfully used for dose summation.
Further work will also focus on measuring the accuracy of the deformation maps and further improvements of the registrations. One of the sources of errors in DIR is the inherent deformation of bony elements, which physically can only move rigidly. Rigidity penalty terms, that constrain the registration to be rigid in regions of interest, are desired in a realistic deformable registration algorithm to increase the accuracy of the tissue mapping. 42 Other similarity measures can also be investigated to improve the robustness of the registrations. 43, 44 The patients included in this study had considerable anatomical changes during the course of their treatment. We consider the tests applied to our registration quite severe as those patients were selected from the group of identified sensitive cases treated in our practice. The registrations were particularly challenging for the dose comparisons since not only anatomical changes but also different positioning systems had to be reproduced. For this reason we expect our routine clinical cases to be less demanding.
The initial clinical application of our method will be weekly offline calculations of the "dose of the day" to help inform the decision of whether the current plan is still acceptable. At this point if a plan is found to be unacceptable our current replan pathway will be followed. Replanned patients will be used on further validation to support the effectiveness and efficiency of the proposed method. With more patients it may be possible to understand the relationship between DIR and dose errors, which could be used to establish quick and easy methods for detecting regions where DIR errors are significant from a dose calculation point of view. On a longer term the aim is for our tool to be employed for the replan procedure itself and remove the need for acquiring a new CT when a new immobilization is not necessary. The final aim is to enable the implementation of a controlled "dose-driven" ART approach that can be built into the patient pathway: to perform routine online modifications to the treatment plan based on the dose that has already been delivered.
CONCLUSIONS
This work presents a proof-of-principle of the application of an in-house developed deformable registration for ART purposes. We have developed, optimized, and evaluated a CTto-CBCT DIR and our experiments have demonstrated that using a pCT scan deformed to match a CBCT scan results in similar dose calculations to those performed on a new CT scan. The dose differences were clinically acceptable, and our method provided dose estimation closer to the gold standard than calculations in a rigidly aligned pCT and extended CBCT. The results obtained support the use of nonrigid registration and provide further evidence in the challenging objective of validating deformable registration for routine clinical use. The work here presented is a first step into a full implementation of a "dose-driven" online ART.
